News from

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2721 Results
Thoughts from a medical ethicist on gene editing babies
Gloved hand taking scissors to a strand of DNA.

Since it started making headlines five years ago, the gene-editing technology CRISPR has been controversial. It’s back in the news after a researcher in China claims to have altered the DNA of twin girls. 

Thoughts from a medical ethicist on gene editing babies

In a Q&A, PIK Professor Jonathan Moreno discusses using CRISPR technology on humans and the future of the field.

Michele W. Berger

Podcast series charts a path for Latin Americans in science
With a microphone between them, Enrique Lin-Shiao and Kevin Alicea-Torres sit for an interview with one of the subjects of their podcast.

Co-founders of the "Caminos en Ciencia" podcast, biomedicine doctoral students Enrique Lin-Shiao and Kevin Alicea-Torres craft their program to highlight the career tracks and accomplishments of Latinx scientists. (Photo: Courtesy of Lin-Shiao and Alicea-Torres)

Podcast series charts a path for Latin Americans in science

Concerned about the scarcity of Latin Americans in scientific careers, doctoral students Kevin Alicea-Torres and Enrique Lin-Shiao took action to prime the pump. On their Spanish-language podcast, “Caminos en Ciencia,” they chat with Latinx scientists who discuss their career paths and provide advice for young scientists-to-be.

Katherine Unger Baillie

CAR T cell therapy leads to lasting remissions
3-d illustration of cancer cells

CAR T cell therapy leads to lasting remissions

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor CAR T cell therapy Kymriah® led to long-lasting remissions in patients with non-Hodgkins lymphoma.

Penn Today Staff

Penn Medicine surgeons perform world’s first robotic breast reconstruction
film still of robotic surgery in action

Photo courtesy: Rebecca Elias Abboud for Penn Medicine

Penn Medicine surgeons perform world’s first robotic breast reconstruction

A team of surgeons from the Perelman School of Medicine are the first in the world to use a surgical robot to assist with a bilateral free flap breast reconstruction, allowing for a minimally invasive procedure that enhances recovery and eliminates narcotics.

Penn Today Staff

Workplace pumping made easier
Dare Henry-Moss leaning against the doorway of a new lactation room, with a breast pump in the background

Dare Henry-Moss, an adjunct fellow at the Center for Public Health Initiatives, developed a recommendation plan for improving lactation support for the University of Pennsylvania Health System, including conducting a needs assessment intended to guide standards for such spaces.

Workplace pumping made easier

Listening to employee feedback, Penn Medicine added hospital-grade pumps and doubled its lactation spaces, taking strides to help women meet their breastfeeding goals.

Michele W. Berger

Why we have hair here, but not there
one-half of a child's face with a fake mustache

Why we have hair here, but not there

A new study answers a fundamental question in human evolution about how and where hair grows on the body, and reveals the existence of a naturally-occurring inhibitor to hair growth.

Penn Today Staff

World AIDS Day: What’s happening with the epidemic today
SERO HIV/AIDS activists together The SERO Project, one of six community organizations featured in this year’s Day With(out) Art program at the Institute of Contemporary Art, is pictured at a workshop event earlier this year. The group advocates for people living with HIV and fights laws that criminalize sexual partners for non-disclosure of HIV status. (Photo courtesy: The Institute of Contemporary Art.)
  • Q&A

    • World AIDS Day: What’s happening with the epidemic today

    Professor of Medicine and Associate Chief of the Infectious Diseases Division Ian Frank explains progress made and challenges still faced in the world of HIV/AIDS research, prevention, and treatment.
    FDA approves new targeted drug for leukemia
    microscopic image of acute myeloid leukemia cells

    FDA approves new targeted drug for leukemia

    The drug is the first to target common mutations associated with relapse and short survival in acute myeloid leukemia.

    Penn Today Staff